Inhaled corticosteroid improved the perception of dyspnea during methacholine induced bronchoconstriction and changed the hypoxic ventilatory response in patients with asthma

S. Shiraishi, K. Hirata, K. Ohtani, K. Asai, J. Yoshikawa (Osaka, Japan)

Source: Annual Congress 2002 - Asthma: Inflammation, hyperreactivity, treatment side effects
Session: Asthma: Inflammation, hyperreactivity, treatment side effects
Session type: Thematic Poster Session
Number: 422
Disease area: Airway diseases

Congress or journal article abstract

Abstract

[Background] An important endogenous factor that contributes to the development of frequent exacerbations in asthma is a diminished perception of breathlessness. It is not well known that inhaled corticosteroid improve the perception of bronchoconstriction and hypoxia in asthma. [Methods] We studied 36 patients with mild asthma (17 male and 19 female, mean age 39.2 yr). They were allocated to the use of either a short-acting beta-2 agonist (salbutamol, n=18: beta group) or an inhaled corticosteroid (fluticasone, n=18: ICS group). We examined the methacholine challenge test and hypoxic ventilatory response (HOVR). In HOVR, we recorded minute ventilation (VE) and the mouth occulusion pressure at 100 msec of inspiration (P 0.1). The severity of dyspnea during the methacholine challenge test and during hypoxia was assessed by a Borg score. Borg scores of all subjects were plotted against percentage of fall in FEV1 from baseline and fall in SpO2 from baseline. Individual Borg/FEV1 slopes (Slope-Borg Mch) and Borg/SpO2 slopes (Slope-Borg HOVR), representing an index of dyspnea, were calculated by liner regression analysis for Mch challenges and HOVR. [Results] In the ICS group, P 0.1 showed significantly lower level than beta group (p=0.046), and the slope-Borg Mch showed higher level than beta group (p=0.0019). The Slope-Borg HOVR did not differ significantly between the beta group and the ICS group. [Conclusion] Inhaled corticosteroid may improve the perception of bronchoconstriction, and changed the HOVR.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Shiraishi, K. Hirata, K. Ohtani, K. Asai, J. Yoshikawa (Osaka, Japan). Inhaled corticosteroid improved the perception of dyspnea during methacholine induced bronchoconstriction and changed the hypoxic ventilatory response in patients with asthma. Eur Respir J 2002; 20: Suppl. 38, 422

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaled corticosteroids decrease cough reflex sensitivity to capsaicin in asthmatics but not in patients with COPD
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008


Bronchodilator response following methacholine-induced bronchoconstriction predicts acute asthma exacerbations
Source: Eur Respir J 2016; 48: 104-114
Year: 2016



Hypertonic histamine challenge induced cough in assessing the treatment response to inhaled corticosteroid in asthma
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008

Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007


The perception of breathlessness during bronchoconstriction induced by mannitol in COPD
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008

Subjects in clinical remission of atopic asthma show normal dyspnoea perception during methacholine and adenosine induced bronchoconstriction
Source: Eur Respir J 2001; 18: Suppl. 33, 46s
Year: 2001

Bronchodilator responsiveness following methacholine-induced bronchoconstriction in children with clinically highly suspected asthma
Source: Annual Congress 2012 - Predicting and observing paediatric allergic disease
Year: 2012

The language of dyspnoea during exercise and induced bronchoconstriction in asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 338s
Year: 2004

sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011


Changes in the pattern of breathing and dyspnoea sensation during methacholine-induced bronchoconstriction in asthmatic patients
Source: Eur Respir J 2001; 18: Suppl. 33, 86s
Year: 2001

Exercise induced bronchoconstriction and dyspnoea in asthmatic children
Source: Annual Congress 2011 - Advances in lung function testing from infancy to adulthood
Year: 2011


Influence of a low dose of BDP-HFA on methacholine or exercise-induced lung hyperinflation in mild asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 508s
Year: 2005

Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough
Source: Annual Congress 2009 - Accuracy in lung function testing
Year: 2009

Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough
Source: Annual Congress 2006 - Established and experimental therapies for allergic asthma
Year: 2006

Bronchial responsiveness and chronic non-productive cough responding to bronchodilator therapy
Source: Annual Congress 2008 - Lung function, airways and cough
Year: 2008

Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children
Source: Eur Respir J 2011; 37: 800-805
Year: 2011



The perception of dyspnea during exercise-induced bronchoconstriction in asthmatic children
Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Year: 2018


Bronchial hypersensitivity and acute bronchodilatory effect of salbutamol on methacholine-induced bronchoconstriction in asthmatics with excessive airway narrowing
Source: Eur Respir J 2004; 24: Suppl. 48, 442s
Year: 2004

Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016
Year: 2017



Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids
Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017
Year: 2017